- Home
- ABOS vs NOTE Comparison
ABOS vs NOTE Comparison
Compare ABOS & NOTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABOS
- NOTE
- Stock Information
- Founded
- ABOS 1996
- NOTE 2013
- Country
- ABOS United States
- NOTE United States
- Employees
- ABOS N/A
- NOTE N/A
- Industry
- ABOS Biotechnology: Pharmaceutical Preparations
- NOTE EDP Services
- Sector
- ABOS Health Care
- NOTE Technology
- Exchange
- ABOS Nasdaq
- NOTE Nasdaq
- Market Cap
- ABOS 82.4M
- NOTE 83.1M
- IPO Year
- ABOS 2021
- NOTE N/A
- Fundamental
- Price
- ABOS $1.42
- NOTE $0.52
- Analyst Decision
- ABOS Strong Buy
- NOTE Strong Buy
- Analyst Count
- ABOS 3
- NOTE 4
- Target Price
- ABOS $6.33
- NOTE $2.44
- AVG Volume (30 Days)
- ABOS 314.6K
- NOTE 2.9M
- Earning Date
- ABOS 08-12-2025
- NOTE 08-07-2025
- Dividend Yield
- ABOS N/A
- NOTE N/A
- EPS Growth
- ABOS N/A
- NOTE N/A
- EPS
- ABOS N/A
- NOTE N/A
- Revenue
- ABOS N/A
- NOTE $109,683,000.00
- Revenue This Year
- ABOS N/A
- NOTE N/A
- Revenue Next Year
- ABOS N/A
- NOTE $41.14
- P/E Ratio
- ABOS N/A
- NOTE N/A
- Revenue Growth
- ABOS N/A
- NOTE N/A
- 52 Week Low
- ABOS $0.86
- NOTE $0.48
- 52 Week High
- ABOS $3.36
- NOTE $2.03
- Technical
- Relative Strength Index (RSI)
- ABOS 53.03
- NOTE 37.80
- Support Level
- ABOS $1.24
- NOTE $0.55
- Resistance Level
- ABOS $1.50
- NOTE $0.61
- Average True Range (ATR)
- ABOS 0.11
- NOTE 0.06
- MACD
- ABOS -0.01
- NOTE -0.01
- Stochastic Oscillator
- ABOS 56.10
- NOTE 0.00
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
About NOTE FiscalNote Holdings Inc.
FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.